Full text

Turn on search term navigation

© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Elizabethkingia anophelis 12012‐2 PRCM was isolated from a patient with multiple organ dysfunction syndrome and lower respiratory tract infection in China. Minimum inhibitory concentration (MIC) analysis demonstrated that it was resistant to 20 antibiotics including trimethoprim/sulfamethoxazole and ciprofloxacin, which were effective for the elimination of other Elizabethkingia infections. To investigate multidrug resistance and pathogenicity mechanisms, we analyzed genome features of 12012‐2 PRCM and compared them to the other Elizabethkingia species. The draft genome size was 4.02 Mb with a GC content of 32%, comparable to that of other E. anophelis strains. Phylogenetic analysis showed that E. anophelis 12012‐2 PRCM formed a sister group with E. anophelis 502, distinct from clades formed by other clinical and environmental E. anophelis isolates. E. anophelis 12012‐2 PRCM contained multiple copies of β‐lactamase genes as well as genes predicted to function in antimicrobial efflux. It also contained 92 genes that were potentially involved in virulence, disease, and defense, and were associated with resistance and pathogenicity. Comparative genomic analysis showed high homology among three clinical and two environmental E. anophelis strains having a variety of similar antibiotic resistance and virulence factor genes, and similar genomic structure. Applications of this analysis will contribute to understanding the antibiotic resistance and pathogenic mechanisms of E. anophelis infections, which will assist in the management of infections as it increases in prevalence.

Details

Title
The antibiotic resistance and pathogenicity of a multidrug‐resistant Elizabethkingia anophelis isolate
Author
Wang, Mingxi 1   VIAFID ORCID Logo  ; Gao, Hongzhi 2 ; Lin, Nanfei 2 ; Zhang, Yaping 3 ; Huang, Nan 4 ; Walker, Edward D 5 ; Desong Ming 6 ; Chen, Shicheng 5 ; Hu, Shaohua 7   VIAFID ORCID Logo 

 Yun Leung Laboratory for Molecular Diagnostics, School of Medicine, Huaqiao University, Xiamen, Fujian, China 
 Clinical Center for Molecular Diagnosis and Therapy, Fujian Medical University 2nd Affiliated Hospital, Quanzhou, Fujian, China 
 Department of Pulmonary and Critical Care Medicine, Fujian Medical University 2nd Affiliated Hospital, Quanzhou, Fujian, China 
 Quanzhou Medical College, Quanzhou, Fujian, China 
 Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan 
 Department of Clinical Laboratory, Quanzhou First Hospital Affiliated to Fujian Medical University, Fujian, China 
 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, China 
Section
ORIGINAL ARTICLES
Publication year
2019
Publication date
Nov 2019
Publisher
John Wiley & Sons, Inc.
e-ISSN
20458827
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2314263519
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.